Connecting to Cure Crohn's and Colitis Inc (EIN 460767240) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

Joshua Hart

Phone

8184251432

Tax Period

2023-01-01 to 2023-12-31

Connecting to Cure Crohn's and Colitis Inc, founded in 2012, is a small nonprofit in the Diseases & Disorders sector that reported $291K in total revenue in fiscal year 2023. Revenue surged 33% from the prior year, signaling strong growth momentum. Expenses of $279K left a modest 4% surplus.

Mission

Connecting to Cure Crohns and Colitis unites the IBD community to promote public awareness and to fund research to find new treatments and a cure for Crohns and colitis

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $254,179

Program Service Revenue $0

Investment Income $0

Other Revenue $36,612

TOTAL REVENUE $290,791

Expense Breakdown

Grants Paid $203,122

Salaries & Benefits $44,382

Fundraising Expenses $9,819

Program Expenses $259,013

Other Expenses $31,353

TOTAL EXPENSES $278,857

Year-over-Year Comparison

	2023	2022	Change
Revenue	$290,791	$219,015	+0.3%
Expenses	$278,857	$236,754	+0.2%
Net Income	$11,934	$-17,739	-1.7%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Stacy Dylan	President, Director	008.00	Officer Director	$0	$0	$0
Dana Zatulove	Secretary, Director	008.00	Officer Director	$0	$0	$0
Joshua Hart	Treasurer, Director	003.00	Officer Director	$0	$0	$0
Patricia Cooper	Director	000.50	Director	$0	$0	$0
Andrew Wolfberg	Director	000.50	Director	$0	$0	$0
Andrew Berman	Director	000.50	Director	$0	$0	$0
Jill Nordquist	Director	000.50	Director	$0	$0	$0
Patrick McGovern	Director	000.50	Director	$0	$0	$0
Richard Standifer	Director	000.50	Director	$0	$0	$0
Kareena Karnani	Director	000.50	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$290,791	$278,857	$41,822	$11,934
2022	$219,015	$236,754	$27,615	$-17,739
2021	$215,470	$235,796	$45,307	$-20,326
2020	$212,938	$231,172	$65,597	$-18,234

Connecting to Cure Crohn's and Colitis Inc